FDA Approves Ozenoxacin Cream for Impetigo
The US Food and Drug Administration has approved ozenoxacin cream (Xepi Cream, Medimetriks Pharmaceuticals Inc) 1% for impetigo. FDA Approvals …read more
Breast cancer: These gene variations may shorten young women’s survival
New research finds that young women with early-onset breast cancer possess variations in a specific gene that might affect their survival. …read more
Prenatal, Early Sugary Drink Exposure Ups Asthma Risk in Kids
Increased maternal consumption of sugary drinks and child total fructose dietary intake were associated with greater odds of asthma in midchildhood in a longitudinal study. Medscape Medical News …read more
Ob/Gyns Not Well Informed About Opioid Prescribing
Obstetricians and gynecologists need to become better informed about prescribing opioids, survey results showed. Medscape Medical News …read more
Fracking Linked to Low Birthweight, Worse Infant Health
Infants born to mothers who lived within 3 km of a fracking site had lower birth weight and worse infant health, a study found; the degree of effects was tied to proximity. Medscape Medical News …read more
FDA Reaffirms Advice Against Use of Morcellators for Fibroids
An updated review leads the FDA to reaffirm their recommendation against the use of power morcellators to remove uterine fibroids in most women. News Alerts …read more
New FDA Web Page Has Latest Info on Best Antibiotic Choice
A new FDA Web page will streamline how the agency updates information to help healthcare providers choose an appropriate antibiotic or antifungal agent for a patient’s infection. …read more
What you should know about tubular breasts
Learn about tubular breasts, a condition where the breasts appear irregularly shaped. Included is detail on risk factors and possible treatment options. …read more
Hormonal Contraception and Risk for Breast Cancer: Many Caveats
This large-scale study is an important contribution to the literature, notes Dr JoAnn Manson, but should it change practice? Medscape Ob/Gyn …read more
Poor Screening Adherence May Worsen Breast Cancer Outcomes
Women who forgo mammography screening may comply less to breast cancer treatment and may have worse outcomes, suggest two European studies, which also found that rates of screening may be falling. Medscape Medical News …read more